NFA
NVO

Nationwide Fund Advisors’s Novo Nordisk NVO Stock Holding History

Nationwide Fund Advisors’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-944,542
Closed -$22.7M – 1409
2017
Q3 		$22.7M Sell
944,542
-36,130
-4% -$816K 0.09% 255
2017
Q2 		$21M Buy
+980,672
New +$19.8M 0.08% 295

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Nationwide Fund Advisors's NVO Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of Novo Nordisk (NVO) in Q4 2017, closing a stake of 944,542 shares — an estimated $22.7M sold.

Nationwide Fund Advisors first reported a position in NVO in Q2 2017 and held it in 2 quarters. The position peaked at $22.7M in Q3 2017. 552 funds tracked by Wall St. Rank hold NVO as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining Novo Nordisk position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 944,542 Novo Nordisk shares in Q4 2017, an estimated $22.7M.
  • Nationwide Fund Advisors first reported a position in Novo Nordisk in Q2 2017 and held it in 2 quarters.
  • Nationwide Fund Advisors's Novo Nordisk position peaked at $22.7M in Q3 2017.
  • 552 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.